[{"from": "human", "value": "Could you give me a brief overview of this molecule? [C][N][C][C@@H1][Branch1][#C][C@H1][Branch1][O][C@@H1][Branch1][#Branch1][C@@H1][Branch1][Ring1][C][O][O][O][O][O].[C][C][N][Branch2][Ring2][Ring1][C][C][N][Branch2][Ring1][#Branch1][C][C][N][Branch1][N][C][C][N][Ring1][N][C][C][=Branch1][C][=O][O][C][C][=Branch1][C][=O][O-1][C][C][=Branch1][C][=O][O-1][C][C][=Branch1][C][=O][O-1].[Gd+3]"}, {"from": "gpt", "value": "The molecule is an organoammonium salt obtained by reaction of gadoteric acid with one equivalent of 1-deoxy-1-(methylamino)-D-glucitol (meglumine). It is used in magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues of patients ages 2 years and older, to detect and visualise areas with disruption of the blood brain barrier and/or abnormal vascularity of the central nervous system. It has a role as a MRI contrast agent. It is an organoammonium salt and a gadolinium coordination entity. It contains a gadoterate."}]